BCTXZ Financials

BriaCell Therapeutics Corp. Warrant - Financial statements & key metrics

Stock Price

$0.19

Market Cap

P/E Ratio

-0.0

EPS

$-62.19

Income Statement Highlights

Most Recent Quarter: 2025-07-31

Revenue

Gross Profit

Operating Income

Net Income

$-26.56M

EPS (Diluted)

$-62.19

Balance Sheet Highlights

Total Assets

$21.65M

Total Liabilities

Shareholders Equity

Cash & Equivalents

$10.49M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-28.17M

CapEx

Free Cash Flow

Profitability Metrics

000

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is BCTXZ revenue?

View BCTXZ's income statement for detailed revenue data.

Is BCTXZ profitable?

BCTXZ reported a loss of $26.56M in the most recent quarter.

What is BCTXZ market cap?

Market cap data for BCTXZ is available above.

Does BCTXZ have debt?

View BCTXZ's balance sheet for debt information.

What is BCTXZ cash flow?

Cash flow data is available in the full financial statements.